Chlorthalidone; clonidine hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for chlorthalidone; clonidine hydrochloride and what is the scope of patent protection?

Chlorthalidone; clonidine hydrochloride is the generic ingredient in three branded drugs marketed by Par Pharm, Natco Pharma, and Boehringer Ingelheim, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

Summary for chlorthalidone; clonidine hydrochloride

US Patents:	0
Tradenames:	3
Applicants:	3
NDAs:	5
Clinical Trials:	2
DailyMed Link:	chlorthalidone; clonidine hydrochloride at DailyMed

Recent Clinical Trials for chlorthalidone; clonidine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Instituto do Coracao	Phase 4
Conselho Nacional de Desenvolvimento Científico e Tecnológico	Phase 4
US Department of Veterans Affairs

See all chlorthalidone; clonidine hydrochloride clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for chlorthalidone; clonidine hydrochloride

US Patents and Regulatory Information for chlorthalidone; clonidine hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Boehringer Ingelheim	COMBIPRES	chlorthalidone; clonidine hydrochloride	TABLET;ORAL	017503-003	Apr 10, 1984		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Boehringer Ingelheim	COMBIPRES	chlorthalidone; clonidine hydrochloride	TABLET;ORAL	017503-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Par Pharm	CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE	chlorthalidone; clonidine hydrochloride	TABLET;ORAL	071178-001	Dec 16, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for chlorthalidone; clonidine hydrochloride

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Boehringer Ingelheim	COMBIPRES	chlorthalidone; clonidine hydrochloride	TABLET;ORAL	017503-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	COMBIPRES	chlorthalidone; clonidine hydrochloride	TABLET;ORAL	017503-003	Apr 10, 1984	⤷ Sign Up	⤷ Sign Up
Boehringer Ingelheim	COMBIPRES	chlorthalidone; clonidine hydrochloride	TABLET;ORAL	017503-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.